- Home
- NAMS vs RNST Comparison
NAMS vs RNST Comparison
Compare NAMS & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | RNST |
|---|---|---|
| Founded | 2019 | 1904 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | RNST |
|---|---|---|
| Price | $35.00 | $41.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $47.38 | $42.25 |
| AVG Volume (30 Days) | 652.7K | ★ 754.1K |
| Earning Date | 02-25-2026 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.20% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | $35,243,000.00 | ★ $878,392,000.00 |
| Revenue This Year | N/A | $30.47 |
| Revenue Next Year | $10.46 | $4.54 |
| P/E Ratio | ★ N/A | $20.19 |
| Revenue Growth | 4.91 | ★ 24.32 |
| 52 Week Low | $14.06 | $26.97 |
| 52 Week High | $42.00 | $42.11 |
Technical Indicators
Market Signals| Indicator | NAMS | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 71.61 |
| Support Level | $31.77 | $37.31 |
| Resistance Level | $33.80 | $42.11 |
| Average True Range (ATR) | 1.48 | 1.25 |
| MACD | 0.37 | 0.43 |
| Stochastic Oscillator | 100.00 | 88.54 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.